Puma Biotechnology Support Services
Puma Biotechnology offers Puma Patient Lynx to assist patients while taking Nerlynx (Table).
Puma Patient Lynx Program
In addition to benefit verification, prior authorization assistance, and support for patients with financial needs, the Puma Patient Lynx program offers the following access and reimbursement services:
- Nerlynx Quick Start provides a free 3-week supply of Nerlynx to eligible patients experiencing delays in accessing Nerlynx therapy
- Nerlynx Co-Pay Card is available for eligible, commercially insured patients (see below for details).
The Puma Patient Lynx program also offers the following ongoing treatment support services:
- Nerlynx Mentor Program provides patient mentors to other patients who are considering or currently taking Nerlynx
- Nurse Call Center is available for patients and healthcare providers to answer questions about Nerlynx. Nurses are available Monday to Friday from 9 am to 8 pm ET at 855-816-5421. Bilingual nurses are available
- Text Message Support Program is available for patients who would like to receive medication reminders and motivational text messages
Click here to learn more or to enroll your patient in Puma Patient Lynx, or call 855-816-5421.
Nerlynx Co-Pay Card
Puma Biotechnology offers copay assistance to help patients with out-of-pocket costs associated with their prescription. To be eligible, patients must:
- Have a prescription for Nerlynx
- Have commercial insurance
- Not participate in Medicare, Medicaid, or any other federal or state program
- Not seek reimbursement for Nerlynx from a third-party payer such as a flexible spending account, a healthcare savings account, or a health reimbursement account.
Click here to learn more or to enroll your patient in the Nerlynx Co-Pay Savings Program, or call 855-816-5421.
TABLE Puma Biotechnology Oncology Drug
Report Broken Links
Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?
Help us fix it! Report broken links here.